Cargando…
Viral Resistance in Hepatitis B: Prevalence and Management
Hepatitis B is a DNA virus affecting hundreds of millions of individuals worldwide. As the clinical sequelae of cirrhosis and hepatocellular cancer are increasingly recognized to be related to viral levels, the impetus increases to offer treatment to those previously not treated. With the developmen...
Autores principales: | Poordad, Fred, Chee, Grace M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832900/ https://www.ncbi.nlm.nih.gov/pubmed/20425486 http://dx.doi.org/10.1007/s11894-009-0088-1 |
Ejemplares similares
-
Big Changes Are Coming in Hepatitis C
por: Poordad, Fred
Publicado: (2010) -
Cost-Efficacy Analysis of Peginterferon alfa-2b plus Ribavirin Compared With Peginterferon alfa-2a plus Ribavirin for the Treatment of Chronic Hepatitis C
por: Malone, Daniel C., et al.
Publicado: (2005) -
Management of nonalcoholic fatty liver disease: Lessons learned from type 2 diabetes
por: Alkhouri, Naim, et al.
Publicado: (2018) -
Prevalence of Viral Hepatitis B, C, and D in Kazakhstan
por: Jumabayeva, Almagul, et al.
Publicado: (2022) -
The prevalence of human immunodeficiency and of hepatitis B viral infections is not increased in patients with sickle cell disease in Tanzania
por: Shayo, Grace, et al.
Publicado: (2021)